Bolt Technology has completed a secondary sale by an early round investor to a group of private investors
Bolt Technology has completed a partial secondary sale of their stake to a group of private investors.
Bolt Technology is an Estonian-based transportation platform providing ride sharing, scooter and food delivery services. It operates across Europe and a number of emerging markets, and has more than 25 million users in over 30 countries. Founded by Markus Villig, Bolt launched in 2013. It is one of the fastest growing transportation platforms in the world, with investors that include Daimler, Didi Chuxing, Korelya Capital and TransferWise's co-founder, Taavet Hinrikus.
The seller is a private investment group which had invested in Bolt Technology in its early stages.
Oaklins' team in Estonia advised an early round private investor in a secondary sale and private book-building, whereby the investor sold a partial stake of its shareholding in the company.


Talk to the deal team
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more